When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Astellas Pharma ( OTCPK:ALPMY ) said that Naoki Okamura will take over as new President and CEO, effective April 1, 2023.
He replaced Kenji Yasukawa who will now take the position of representative director and chairman of the Board.
Okamura currently serves the representative director, executive VP post.
Claus Zieler will be appointed as CCO. He joined Astellas Group in 2019 as President, International Markets Commercial with experience in the commercial area at Schering and Bayer.